Algert Global’s Cano Health, Inc. CANO Stock Holding History

Algert Global’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-513	Closed	-$445K	–	1329
2022 Q3	$445K	Buy	+513	New	+$322K	0.03%	838

Other funds holding CANO

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Algert Global's CANO Position: Q4 2022 in Review

Algert Global sold out of Cano Health, Inc. (CANO) in Q4 2022, closing a stake of 513 shares — an estimated $445K sold.

Algert Global first reported a position in CANO in Q3 2022 and held it in 1 quarter. The position peaked at $445K in Q3 2022. 186 funds tracked by Wall St. Rank hold CANO as of Q4 2022.

Algert Global reported no remaining Cano Health, Inc. position as of Q4 2022 after selling out during the quarter.
Algert Global sold 513 Cano Health, Inc. shares in Q4 2022, an estimated $445K.
Algert Global first reported a position in Cano Health, Inc. in Q3 2022 and held it in 1 quarter.
Algert Global's Cano Health, Inc. position peaked at $445K in Q3 2022.
186 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2022.

Based on Algert Global's 13F filing for Q4 2022, filed 14 Feb 2023.